Epidemiology of Human Papillomavirus Infection and Cervical Cancer and Future Perspectives in Hong Kong, Singapore and Taiwan
Authors:
- Sun Kuie TaySTSun Kuie Tay
- Hextan Y.S. NganHNHextan Y.S. Ngan
- Tang-Yuan ChuTCTang-Yuan Chu
- Annie N.Y. CheungACAnnie N.Y. Cheung
- Eng Hseon TayETEng Hseon Tay
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative studySexually Transmitted Infections, 2008
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case–control studyJournal of General Virology, 2007
- The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group StudyInternational Journal of Gynecological Cancer, 2006
- Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancerGynecologic Oncology, 2006
- Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesisInternational Journal of Gynecological Cancer, 2006
- Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene–gene interactionGynecologic Oncology, 2005
- Genetic polymorphism of the interferon‐γ gene in cervical carcinogenesisInternational Journal of Cancer, 2004
- Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesisInternational Journal of Cancer, 2002